Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BRIEF-ANI Pharmaceuticals Q3 Adjusted EPS USD 2.7 Vs. IBES Estimate USD 2.18

BRIEF-ANI Pharmaceuticals Q3 Adjusted EPS USD 2.7 Vs. IBES Estimate USD 2.18

ReutersReuters2026/11/05 11:52

Nov 05 (Reuters) - ANI Pharmaceuticals Q3 EPS USD 1.51.

  • Q3 adjusted EBITDA USD 83.3 million
  • Q3 net income USD 35.1 million
  • outlook FY adjusted EBITDA USD 290-300 million
  • outlook FY revenue USD 1,085-1,125 million vs. IBES estimate USD 1,102 million
  • outlook FY adjusted EPS USD 9.37-9.71 vs. IBES estimate USD 9.26
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!